PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Einstein researchers find osteoporosis drug may help women with kidney disease

2010-10-08
(Press-News.org) October 6, 2010 — (BRONX, NY) — The osteoporosis drug raloxifene may be useful in treating kidney disease in women, suggests a new study led by Michal Melamed, M.D., M.H.S., assistant professor of medicine and epidemiology & population health at the Albert Einstein College of Medicine of Yeshiva University.

According to government statistics, an estimated 23 million American adults over age 20 suffers from chronic kidney disease―more than one out of 10. More than a half-million patients are under treatment for end-stage renal disease. New treatments are urgently needed.

In the study, published in the October 6 online edition of Kidney International, Dr. Melamed and Sharon Silbiger, M.D., professor of clinical medicine and associate chair for undergraduate medical education at Einstein, looked at data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial, a study of 7,705 post-menopausal women with osteoporosis conducted from 1994 to 1999. The women were randomly assigned to take either 60 or 120 mg of raloxifene (Evista) per day or a placebo, and were given a blood test yearly to assess kidney function.

After three years, women taking raloxifene had less of a decline in kidney function than women taking a placebo. More specifically, compared with women in the placebo group, women on the 60 mg raloxifene dose had a statistically significant slower yearly rate of increase in the blood creatinine level, high levels of which are an indicator of poor kidney function. Women on both doses of raloxifene experienced a statistically significant slowing in the decrease of their glomerular filtration rate (GFR). GFR naturally declines with age. A significant decline can be an early indicator of kidney disease that requires intervention. Physicians are looking for medications that slow the decline in GFR, and this study shows that raloxifene may have this effect.

"There are few treatments for kidney disease, so if further studies confirm these findings, raloxifene potentially could be widely used as another treatment. What's needed now is a rigorous study on raloxifene in women with advanced kidney disease," Dr. Melamed said. She noted that because raloxifene works on estrogen receptors, the drug might cause side effects if given to men.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

Mount Etna's mystery explained?

Mount Etnas mystery explained?
2010-10-08
Internationally renowned geophysicist Dr Wouter Schellart has developed the first dynamic model to explain the mystery of the largest and most fascinating volcano in Europe, Mount Etna. Dr Schellart's results from fluid dynamic models provide an alternative explanation for the existence of Mount Etna, its geological environment and evolution, as well as volcanism in the surrounding region. His theory suggests that Mount Etna is not directly the result of tectonic plate boundary activity, but that it resulted from decompression melting of upper mantle material flowing ...

Gut microbes promote cell turnover by a well-known pathway

Gut microbes promote cell turnover by a well-known pathway
2010-10-08
Microbes matter -- perhaps more than anyone realizes -- in basic biological development and, maybe, they could be a target for reducing cancer risks, according to University of Oregon researchers. In a study of very basic biology of zebrafish, scientists in the UO Institute of Molecular Biology focused on the developing intestine during its early formation in the sterile environment of its eggshell through the exposure to natural colonizing bacteria after hatching. What they found was eye opening, said Karen Guillemin, professor of biology: Resident microbes in the ...

Scientists give extinct passenger pigeon a place on the family tree

2010-10-08
With bits of DNA extracted from century-old museum specimens, researchers have found a place for the extinct Passenger Pigeon (Ectopistes migratorius) in the family tree of pigeons and doves, identifying this unique bird's closest living avian relatives for the first time. The new analysis, which appears this month in Molecular Phylogenetics and Evolution, reveals that the Passenger Pigeon was most closely related to other North and South American pigeons, and not to the Mourning Dove, as was previously suspected. "This research demonstrates the remarkable potential of ...

Doctors evaluating heart problems should consider checking fat deposits around the heart

2010-10-08
LOS ANGELES (Oct. 6, 2010) – Cardiac imaging researchers at Cedars-Sinai Heart Institute are recommending that physicians not overlook fatty deposits around the heart when evaluating patients for risk of major heart problems. Although abdominal fat is often considered in making these assessments, recent research suggests that measuring fatty tissue around the heart is an even better predictor, and noninvasive CT scanning may provide this important information. The recommendation appeared in an editorial comment published in the Journal of the American College of Cardiology: ...

Call to heal the world's coral reefs

2010-10-08
There is still time to save the world's ailing coral reefs, if prompt and decisive action can be taken to improve their overall health, leading marine researchers say. Writing in the journal Trends in Ecology and Evolution, eminent marine scientists from Australia and the USA have called for an international effort to improve the resilience of coral reefs, so they can withstand the impacts of climate change and other human activities. "The world's coral reefs are important economic, social and environmental assets, and they are in deep trouble. How much trouble, and ...

Disability and Health Journal critically examines Americans with Disabilities Act

2010-10-08
New York, NY, October 6, 2010 – In recognition of the 20th anniversary of the enactment of the Americans with Disabilities Act (ADA), the October issue of Disability and Health Journal has brought together a series of articles to examine whether the ADA has in fact improved the health of people with disabilities. Areas of progress are identified, most notably acknowledging physical barriers and need for better staff training and communication about and with people with disabilities. However, there continue to be ongoing challenges, including recurrent barriers to health ...

Missing self-injury behavior in youths with eating disorders, Stanford/Packard study finds

2010-10-08
STANFORD, Calif. - An alarming number of adolescents already battling eating disorders are also intentionally cutting themselves, and health-care providers may be failing to diagnose many instances of such self-injury, according to a new study from Stanford University School of Medicine and Lucile Packard Children's Hospital. The researchers found that 40.8 percent of patients with eating disorders in their study had documented incidents of intentionally harming themselves, most often by cutting and burning. What's more, the study suggests that inadequate clinical screening ...

Genetically modified crop resistance to pests benefits non-modified crop, U of Minnesota study finds

2010-10-08
Transgenic corn's resistance to pests has benefitted even non-transgenic corn, a new study led by scientists from the University of Minnesota shows. The study, published in the Oct. 8 edition of the journal Science, found that widespread planting of genetically modified Bt corn throughout the Upper Midwest has suppressed populations of the European corn borer, historically one of corn's primary pests. This areawide suppression has dramatically reduced the estimated $1 billion in annual losses caused by the European corn borer, even on non-genetically modified corn. Bt ...

Scientists reveal first structure of a class of proteins that help guide blood cell movement

2010-10-08
LA JOLLA, CA – October 4, 2010 – Researchers have determined the structure of a protein that helps guide blood-forming stem cells, or hematopoetic stem cells. The protein is also one of the main receptors used by the human immunodeficiency virus (HIV) to get inside blood cells. The findings are described in the October 7, 2010 issue of the journal Science. The structure offers a detailed view of how the cell surface receptor, called CXCR4, interacts with molecules outside the cell. The results have implications for developing new drugs for hematopoetic stem cell transplantation, ...

Study details structure of potential target for HIV and cancer drugs

Study details structure of potential target for HIV and cancer drugs
2010-10-08
VIDEO: This model shows how HIV, in gray, might latch on to immune cell receptor molecules, allowing the virus to enter and infect the cell. The viral protein, gp120, shown in... Click here for more information. In a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many forms of cancer. The high-resolution structure sheds light on how the ...

LAST 30 PRESS RELEASES:

Scientists uncover DNA secrets to bolster corn crop traits

Hidden bacterial redundancy could be antibiotic game-changer

New study reveals how corals teach their offspring to beat the heat

Understanding relationship development: Towards a more rigorous approach

Surgical stroke initiative targets deadliest brain bleeds

Understanding how the superfungus Candida auris withstands antifungal treatment

Call for papers: CPA special issue on polypharmacology in cancer therapy—overcoming resistance and enhancing efficacy

An alternative adhesive for wearable medical devices

Pavlov’s dogs were conditioned to go to their treat. Why do some animals learn to interact with the bell instead?

Call for Young Editorial Board members at Current Molecular Pharmacology

MSU team develops scalable climate solutions for agricultural carbon markets

Playing an instrument may protect against cognitive aging

UNM study finds link between Grand Canyon landslide and Meteor Crater impact

Ultra-hot Jupiter’s death spiral could reveal stellar secrets

You only get one brain! The best helmet material for protecting your noggin

Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity

Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023

Research spotlight: New genetic roadmap offers insights into obesity and diabetes

Fred Hutch leads new Vanguard Study for Cancer Screening Research Network

‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds

New research helps narrow down uncertainties in near-term precipitation projections for the Asian Water Tower

AI tool accurately detects tumor location on breast MRI

Researchers use OCT imaging to uncover how the fallopian tube transports embryos

PolyU secures RGC theme-based research scheme funding to develop cost-effective and sustainable Co-GenAI model

Van Andel Institute scientists develop technique for high-resolution single cell epigenetic analysis

The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis

Review suggests ending adult boosters for tetanus, diphtheria

ESMT Berlin welcomes Rebecca Schaumberg to faculty

Blocking a little-known protein may offer new hope for devastating lung disease

Medieval medicine was smarter than you think – and weirdly similar to TikTok trends

[Press-News.org] Einstein researchers find osteoporosis drug may help women with kidney disease